Recent Quarter Total Invested
$60.01 M
Recent Quarter Institutional Ownership Percentage
59.77%
Total Invested of Last Quarter
$61.86 M
Ownership Percentage of Last Quarter
61.79%
CytomX Therapeutics, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
TANG CAPITAL MANAGEMENT LLC | 11/14/2024 | 7.81 M | $9.22 M | 0.25% | 9.18% |
BVF INC/IL | 11/14/2024 | 5.23 M | $6.17 M | 0.00% | 6.14% |
JANUS HENDERSON GROUP PLC | 11/14/2024 | 4.81 M | $5.70 M | -23.68% | 5.65% |
ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 3.10 M | $3.66 M | 13.65% | 3.64% |
PROSIGHT MANAGEMENT, LP | 11/14/2024 | 3.02 M | $3.57 M | 100.00% | 3.55% |
ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 3.00 M | $3.54 M | 0.00% | 3.53% |
MILLENNIUM MANAGEMENT LLC | 11/14/2024 | 2.56 M | $3.02 M | 38.74% | 3.01% |
ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 1.64 M | $1.94 M | 32.75% | 1.93% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 1.52 M | $1.80 M | 1.09% | 1.79% |
LAURION CAPITAL MANAGEMENT LP | 11/14/2024 | 1.25 M | $1.47 M | -18.21% | 1.47% |
CONGRESS PARK CAPITAL LLC | 10/09/2024 | 1.22 M | $1.43 M | 5.44% | 1.43% |
SCHONFELD STRATEGIC ADVISORS LLC | 11/14/2024 | 1.21 M | $1.43 M | -11.89% | 1.42% |
BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 1.17 M | $1.38 M | 100.00% | 1.37% |
RENAISSANCE TECHNOLOGIES LLC | 11/13/2024 | 1.02 M | $1.20 M | -14.20% | 1.19% |
ALTIUM CAPITAL MANAGEMENT LP | 11/14/2024 | 915,000 | $1.08 M | 100.00% | 1.08% |
ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2024 | 903,959 | $1.07 M | 57.99% | 1.06% |
GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 803,531 | $948,369 | 4.42% | 0.94% |
SEI INVESTMENTS CO | 11/12/2024 | 487,902 | $575,724 | 27.48% | 0.57% |
TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 471,468 | $556,332 | -28.78% | 0.55% |
WOODLINE PARTNERS LP | 11/14/2024 | 393,832 | $464,722 | 100.00% | 0.46% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 11/14/2024 | 356,624 | $420,816 | -3.39% | 0.42% |
CITADEL ADVISORS LLC | 11/14/2024 | 317,119 | $374,200 | -35.89% | 0.37% |
CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 280,593 | $331,100 | 10.37% | 0.33% |
STATE STREET CORP | 11/14/2024 | 263,643 | $311,099 | 0.00% | 0.31% |
FORMIDABLE ASSET MANAGEMENT, LLC | 11/12/2024 | 246,001 | $290,281 | -4.65% | 0.29% |
BANK OF NEW YORK MELLON CORP | 11/12/2024 | 241,982 | $285,539 | 0.00% | 0.28% |
SQUAREPOINT OPS LLC | 11/14/2024 | 109,000 | $128,620 | 100.00% | 0.13% |
CREATIVE PLANNING | 10/11/2024 | 107,000 | $126,260 | 0.00% | 0.13% |
VIRTU FINANCIAL LLC | 11/20/2024 | 88,518 | $104,000 | 100.00% | 0.10% |
UBS GROUP AG | 11/14/2024 | 69,135 | $81,579 | -1.75% | 0.08% |
FOREFRONT ANALYTICS, LLC | 11/14/2024 | 59,760 | $70,518 | -6.72% | 0.07% |
QUBE RESEARCH & TECHNOLOGIES LTD | 11/14/2024 | 55,108 | $65,027 | 0.92% | 0.06% |
COMMONWEALTH EQUITY SERVICES, LLC | 10/18/2024 | 54,243 | $64,000 | 0.00% | 0.06% |
PRIVATE ADVISOR GROUP, LLC | 10/22/2024 | 52,179 | $61,571 | 0.00% | 0.06% |
MORGAN STANLEY | 11/14/2024 | 50,368 | $59,434 | -73.28% | 0.06% |
RUSSELL INVESTMENTS GROUP, LTD. | 11/13/2024 | 47,649 | $56,224 | 11.29% | 0.06% |
STIFEL FINANCIAL CORP | 11/14/2024 | 46,100 | $54,398 | -2.12% | 0.05% |
XTX TOPCO LTD | 11/14/2024 | 43,664 | $51,524 | -27.93% | 0.05% |
CORNERCAP INVESTMENT COUNSEL INC | 11/06/2024 | 41,458 | $48.92 M | -48.56% | 0.05% |
LPL FINANCIAL LLC | 11/08/2024 | 38,315 | $45,212 | 5.51% | 0.05% |
INVESCO LTD. | 11/12/2024 | 37,464 | $44,208 | 62.22% | 0.04% |
US BANCORP \DE\ | 10/28/2024 | 33,792 | $39,875 | 100.00% | 0.04% |
AJOVISTA, LLC | 11/12/2024 | 33,121 | $39.08 M | 100.00% | 0.04% |
HRT FINANCIAL LP | 11/12/2024 | 26,840 | $31,000 | 100.00% | 0.03% |
CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 24,817 | $29,284 | 0.00% | 0.03% |
CUBIST SYSTEMATIC STRATEGIES, LLC | 11/14/2024 | 24,460 | $28,863 | -70.19% | 0.03% |
BANK OF AMERICA CORP /DE/ | 11/14/2024 | 20,561 | $24.26 M | 257.96% | 0.02% |
NIERENBERG INVESTMENT MANAGEMENT COMPANY, INC. | 11/13/2024 | 12,555 | $14,815 | 0.00% | 0.01% |
IPG INVESTMENT ADVISORS LLC | 11/13/2024 | 12,500 | $14,750 | 0.00% | 0.01% |
GOLDMAN SACHS GROUP INC | 11/14/2024 | 12,000 | $14,160 | -89.02% | 0.01% |
CytomX Therapeutics, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CTMX shares?
During the previous two years, 99 institutional investors and hedge funds held shares of CytomX Therapeutics, Inc.. The most heavily invested institutionals were:
TANG CAPITAL MANAGEMENT LLC: 7.81 M
BVF INC/IL: 5.23 M
JANUS HENDERSON GROUP PLC: 4.81 M
ACADIAN ASSET MANAGEMENT LLC: 3.1 M
Prosight Management, LP: 3.02 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3 M
-
What percentage of CytomX Therapeutics, Inc. stock is owned by institutional investors?
59.77% of CytomX Therapeutics, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CTMX ?
Institutional investors have bought a total of 49.21 M shares in the last 24 months. This purchase volume represents approximately $41.83 M in transactions.